anti-CAV1 antibody product blog
Tags: Antibody; Monoclonal Antibody; CAV1; anti-CAV1 antibody; Caveolin-1;
The CAV1 cav1 (Catalog #MBS2540162) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CAV1 Monoclonal Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CAV1 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), ELISA (EIA).WB: 1:500-1:5000
IHC: 1:20-1:200. Researchers should empirically determine the suitability of the CAV1 cav1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CAV1 cav1 product has the following accession number(s) (GI #15451856) (NCBI Accession #NP_001744.2) (Uniprot Accession #Q03135). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CAV1 Monoclonal Antibody with the following immunoassay(s):
Western Blot (WB) (Western Blot analysis of PC-3 cells using Caveolin-1 Monoclonal Antibody at dilution of 1:1000)
Caveolin-1 (CAV1), a multifunctional protein, is the main constituent molecule of caveolae and represents a scaffolding molecule for several signaling molecules including epidermal growth factor receptor. Several studies have implicated that a reduced expression of CAV1 was found in cancers including head and neck carcinoma. However, other studies recognize CAV1 as a tumor promoter because CAV1 is overexpressed in various kinds of cancers, especially in oral cancer. Recent study also show that CAV1 is involved in astric Cancer.
Immunogen: Fusion protein of Caveolin-1. Buffer: PBS with 0.02% sodium azide, 50% glycerol, PH7.3
Conjugation: Unconjugated. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CAV1 are readily searchable from our website. Different antibodies against the same target such as CAV1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Adenocarcinoma, Breast Neoplasms, Cardiovascular Diseases, Fibrosis, Heart Diseases, Hypertension, Inflammation, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms are some of the diseases may be linked to CAV1 Monoclonal Antibody. Blood, Brain, Embryonic Tissue, Heart, Kidney, Lung, Muscle, Nerve, Prostate, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene. CAV1 also interacts with the following gene(s): ABCB1, CAV2, CSK, EGFR, FYN, MAPK1, MAPK3, NOS3, RHOA, SRC.